HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy Management of Urolithiasis: Flexible Ureteroscopy versus Extracorporeal Shockwave Lithotripsy.

AbstractOBJECTIVES:
To evaluate the efficacy of flexible ureterscopy (fURS) and extracorporal shockwave lithotripsy (SWL) in the treatment of urolithiasis, complemented by a subgroup analysis of lower pole calyx.
METHODS:
Retrospective analysis of patients treated by fURS or SWL was performed by independent variables such as gender, age, nephrolith size, double-J stent (DJ stent) and stone localisation.
RESULTS:
Out of 326 patients, 165 were treated by SWL and 161 by fURS. Complete stone removal was achieved by fURS in 83.2% and by SWL in 43.0% (p < 0.001). Asymptomatic behaviour (88-89%) and complication rate (10-11%) were nearly the same in both methods. A higher retreatment rate for SWL was necessary; otherwise, an auxillary DJ stent was performed more often preoperative before fURS. The subgroup analysis of lower pole calyx confirmed these evaluations.
CONCLUSIONS:
Complete stone-free removal was almost 8 times higher after fURS compared to SWL. The efficacy of fURS in treatment of urolithiasis is substantially higher than the efficacy of SWL.
AuthorsVolkmar Tauber, Martin Wohlmuth, Andreas Hochmuth, Wolfgang Schimetta, Wofgang Schimetta, F Steffen Krause
JournalUrologia internationalis (Urol Int) Vol. 95 Issue 3 Pg. 324-8 ( 2015) ISSN: 1423-0399 [Electronic] Switzerland
PMID26393912 (Publication Type: Comparative Study, Journal Article)
Copyright© 2015 S. Karger AG, Basel.
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Lithotripsy
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Ureteroscopes
  • Ureteroscopy
  • Urolithiasis (therapy)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: